Company: TCMD
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001558370-25-003924
Chunk: 8

Company: TACTILE SYSTEMS TECHNOLOGY INC
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 8
---
 technology and data security risks and threats, the potential impact of those risks and threats on our business, operations and reputation, and management’s processes, procedures and actions to identify, assess, monitor, mitigate and remediate such risks and threats; and 
 ●Establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing matters and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters.                                         |             7 |

The Audit Committee operates under a written charter approved by the Board, a copy of which is available in the “Investors—Corporate Governance” section of our website at www.tactilemedical.com.

| ​                    |  ​ |
| 2025 Proxy Statement | 17 |

Compensation and Organization Committee Our Board of Directors has determined that each member of the Compensation and Organization Committee is “independent” as that term is defined in the rules of the SEC and the applicable Nasdaq Stock Market rules.

| ​                                                               | ​                                                                                                                                                                                                                                                                    |             ​ |
| ​                                                               | ​                                                                                                                                                                                                                                                                    | 

# of Meetings |
| Committee Members                                               | Primary Responsibilities                                                                                                                                                                                                                                             |       in 2024 |
| Raymond O. Huggenberger (Chair)D. Brent ShaferCarmen B. Volkart | ●Determining the compensation of our Chief Executive Officer and other executive officers;                                                                                                                                                                           
 ●Providing oversight of our compensation policies, plans and benefit programs;                                                                                                                                                                                       
 ●Overseeing and administering our equity compensation plans;                                                                                                                                                                                                         
 ●Recommending to our Board of Directors the compensation arrangements for our non-employee directors;                                                                                                                                                                
 ●Overseeing and reviewing our executive team and management succession planning; and                                                                                                                                                                                 
 ●Reviewing the Company’s human capital management programs, policies, initiatives and results, including with respect to: talent management; culture; employee recruitment, training, development, promotion and retention; pay equity; and anti-harassment matters. |             6 |

The Compensation and Organization Committee operates under a written charter approved by the Board, a copy of which is available in the “Investors—Corporate Governance” section of our website at www.tactilemedical.com. Nominating and Corporate Governance Committee Our Board of Directors has determined that each member of the Nominating and Corporate Governance Committee is “independent” as that term is defined in the applicable Nasdaq Stock Market rules.

| ​                                                               | ​                                                                                     |             ​ |
| ​                                                               | ​                                                                                     | 

# of